Shi; Jack Guoen

Patent Applications and Registrations

Patent applications and USPTO patent grants for Shi; Jack Guoen.The latest application filed is for "pharmaceutical compositions and methods for indoleamine, 2, 3-dioxygenase inhibition and indications therefor".

Company Profile

3.4.7

Shi; Jack Guoen - Wilmington DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Pharmaceutical Compositions And Methods For Indoleamine, 2, 3-dioxygenase Inhibition And Indications Therefor App 20200179347 - Yeleswaram; Krishnaswamy ; et al.	2020-06-11
METABOLITES OF THE JANUS KINASE INHIBITOR (R)-3-(4-(7H-PYRROLO[2,3-d]PYRIMIDIN-4-YL)-1H-PYRAZOL-1-YL)-3-CYCLOPENTYL- PROPANENITR App 20200038404 - Rodgers; James D. ; et al.	2020-02-06
Metabolites of the janus kinase inhibitor (R)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentyl- propanenitrile Grant 10,463,667 - Rodgers , et al. No	2019-11-05
Pharmaceutical Compositions And Methods For Indoleamine, 2, 3-dioxygenase Inhibition And Indications Therefor App 20180353483 - Yeleswaram; Krishnaswamy ; et al.	2018-12-13
METABOLITES OF THE JANUS KINASE INHIBITOR (R)-3-(4-(7H-PYRROLO[2,3-d]PYRIMIDIN-4-YL)-1H-PYRAZOL-1-YL)-3-CYCLOPENTYL- PROPANENITRILE App 20170326144 - Rodgers; James D. ; et al.	2017-11-16
METABOLITES OF THE JANUS KINASE INHIBITOR (R)-3-(4-(7H-PYRROLO[2,3-d]PYRIMIDIN-4-YL)-1H-PYRAZOL-1-YL)-3-CYCLOPENTYL- PROPANENITRILE App 20150164900 - Rodgers; James D. ; et al.	2015-06-18
Metabolites of the janus kinase inhibitor (R)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentyl- propanenitrile Grant 8,889,697 - Rodgers , et al. November 18, 2	2014-11-18
METABOLITES OF THE JANUS KINASE INHIBITOR (R)-3-(4-(7H-PYRROLO[2,3-d]PYRIMIDIN-4-YL)-1H-PYRAZOL-1-YL)-3-CYCLOPENTYL- PROPANENITRILE App 20110082159 - RODGERS; James D. ; et al.	2011-04-07
Metabolites of the Janus kinase inhibitor (R)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentyl- propanenitrile Grant 7,834,022 - Rodgers , et al. November 16, 2	2010-11-16
METABOLITES OF THE JANUS KINASE INHIBITOR (R)-3-(4-(7H-PYRROLO[2,3-d]PYRIMIDIN-4-YL)-1H-PYRAZOL-1-YL)-3-CYCLOPENTYL- PROPANENITRILE App 20080312258 - Rodgers; James D. ; et al.	2008-12-18

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.